“Cloture Motion (Executive Session)” published by Congressional Record in the Senate section on Feb. 16

0Comments

Christopher A. Coons was mentioned in Cloture Motion (Executive Session) on pages S731-S732 covering the 2nd Session of the 117th Congress published on Feb. 16 in the Congressional Record.

The publication is reproduced in full below:

Cloture Motion

The PRESIDING OFFICER. Pursuant to rule XXII, the Chair lays before the Senate the pending cloture motion, which the clerk will state.

The legislative clerk read as follows:

Cloture Motion

We, the undersigned Senators, in accordance with the provisions of rule XXII of the Standing Rules of the Senate, do hereby move to bring to a close debate on the nomination of Executive Calendar No. 692, Celeste Ann Wallander, of Maryland, to be an Assistant Secretary of Defense.

Charles E. Schumer, Jack Reed, Christopher A. Coons,

Benjamin L. Cardin, Joe Manchin III, Catherine Cortez

Masto, Debbie Stabenow, Tammy Baldwin, Christopher

Murphy, Margaret Wood Hassan, Tammy Duckworth, Jeanne

Shaheen, Michael F. Bennet, Tina Smith, Brian Schatz,

Mark R. Warner, Richard J. Durbin.

The PRESIDING OFFICER. By unanimous consent, the mandatory quorum call has been waived.

The question is, Is it the sense of the Senate that debate on the nomination of Celeste Ann Wallander, of Maryland, to be an Assistant Secretary of Defense, shall be brought to a close?

The yeas and nays are mandatory under the rule.

The clerk will call the roll.

The legislative clerk called the roll.

Mr. DURBIN. I announce that the Senator from California (Mrs. Feinstein), the Senator from Arizona (Mr. Kelly), the Senator from New Mexico (Mr. Lujan), and the Senator from Vermont (Mr. Sanders) are necessarily absent.

Mr. THUNE. The following Senators are necessarily absent: the Senator from South Carolina (Mr. Graham) and the Senator from Pennsylvania (Mr. Toomey).

The yeas and nays resulted–yeas 81, nays 13, as follows:

YEAS–81

Baldwin Barrasso Bennet Blumenthal Blunt Booker Boozman Brown Burr Cantwell Capito Cardin Carper Casey Cassidy Collins Coons Cornyn Cortez Masto Cotton Cramer Crapo Daines Duckworth Durbin Fischer Gillibrand Grassley Hassan Heinrich Hickenlooper Hirono Hoeven Hyde-Smith Inhofe Kaine Kennedy King Klobuchar Leahy Manchin Markey Marshall McConnell Menendez Merkley Murkowski Murphy Murray Ossoff Padilla Paul Peters Portman Reed Risch Romney Rosen Rounds Rubio Sasse Schatz Schumer Scott (FL) Shaheen Shelby Sinema Smith Stabenow Sullivan Tester Thune Tillis Van Hollen Warner Warnock Warren Whitehouse Wicker Wyden Young

NAYS–13

Blackburn Braun Cruz Ernst Hagerty Hawley Johnson Lankford Lee Lummis Moran Scott (SC) Tuberville

NOT VOTING–6

Feinstein Graham Kelly Lujan Sanders Toomey

The PRESIDING OFFICER. On this vote, the yeas are 81, the nays 13.

The motion is agreed to.

____________________

SOURCE: Congressional Record Vol. 168, No. 31

The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.

Senators’ salaries are historically higher than the median US income.



Related

Mike Dunleavy, Governor of Alaska

Delaware sees 4.4% rise in individual income taxes collections in 2024

Out of the $6.5 billion in total tax revenue collected by Delaware in 2024, $2.5 billion came from individual income taxes, representing an increase from the previous year, when the total was $2.4 billion, according to the U.S. Census Bureau’s Annual Survey of State Government Tax Collections (STC).

John T. Dorsey Chief Judge at U.S. Bankruptcy Court for the District of Delaware

Judge John T. Dorsey remembered after passing following battle with cancer

Judge John T. Dorsey has passed away following a battle with cancer, according to an announcement from the U.S. Bankruptcy Court for the District of Delaware on Apr. 15. He served as Chief Judge from 2024-2025 and had a long career dedicated to public service.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA inspection: Which types of Delaware companies faced the most scrutiny in March?

The U.S. Food and Drug Administration (FDA) carried out inspections at two food and cosmetics companies in Delaware during March.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.